On December 4, 2014, Guangzhou Oasis Biochem Technology Co., Ltd. (“Oasis Biochem”, stock code: 430437), an NEEQ-listed company, released an announcement made at the shareholders’ meeting that the company would acquire 100% stake of Guangdong Dayuan Food & Drug Safety Technology Co., Ltd., a subsidiary of SZSE-listed DaAn Gene Co., Ltd., by offering shares to chosen investors to raise funds needed.

Oasis Biochem, which focuses on the R&D, manufacture and sale of instant detection reagent of chemicals in food, was listed on the National Equities and Exchange Quotations (“NEEQ”) system on January 24, 2014. The major assets reorganization of Oasis Biochem, conducted in accordance with “Measures for the Administration of Major Assets Reorganization of Unlisted Public Companies” and “Guidance on Major Assets Reorganization of Unlisted Public Companies on National Equities Exchange and Quotations System (Trial)”, is the first such case in the history of the NEEQ system. Currently, the reorganization has passed NEEQ examination on the completeness of files. Guangzhou-based attorneys Zhao Ya and Yan Shuang provided comprehensive legal counsel on the reorganization.